
Pfizer Strikes $900 Million Manufacturing Deal with Samsung Biologics
Pfizer has entered into two manufacturing deals worth $897 million with Samsung Biologics, a South Korean company, to produce pharmaceutical products.
All articles tagged with #manufacturing deal

Pfizer has entered into two manufacturing deals worth $897 million with Samsung Biologics, a South Korean company, to produce pharmaceutical products.